...
机译:Warfarin预防心房颤动的血栓栓塞:“真实世界”密歇根抗凝质量改善倡议(Maqi 2)登记处的患者特征和结果与Re-Ly,Rocket-AF和Aristotle试验的比较
Frankel Cardiovascular Center University of Michigan Health System;
Frankel Cardiovascular Center University of Michigan Health System;
Frankel Cardiovascular Center University of Michigan Health System;
Frankel Cardiovascular Center University of Michigan Health System;
Michigan Heart Group William Beaumont Hospital;
Cardiology and Vascular Associates Huron Valley-Sinai Hospital;
West Michigan Heart;
Henry Ford Hospital;
Henry Ford Hospital;
Hurley Medical Center;
Frankel Cardiovascular Center University of Michigan Health System;
Frankel Cardiovascular Center University of Michigan Health System;
Atrial fibrillation; Anticoagulation; Warfarin; Real world; Outcomes;
机译:Warfarin预防心房颤动的血栓栓塞:“真实世界”密歇根抗凝质量改善倡议(Maqi 2)登记处的患者特征和结果与Re-Ly,Rocket-AF和Aristotle试验的比较
机译:低卒中风险的房颤患者使用华法林:密歇根州抗凝质量改善计划(MAQI2)的分析
机译:Warfarin用于心房颤动患者的中风的低风险:分析密歇根抗菌质量改善倡议(MAQI2)
机译:房颤的医疗补助患者的临床特征口服抗凝模式和结果:从结果登记处获得的见解可以更好地进行房颤知情治疗(ORBIT‐AF I)登记处
机译:华法林预防房颤中的血栓形成性疾病:密歇根州立大学,密歇根州立大学,密歇根州立大学,密歇根州立大学,医学博士